Compare · head to head
Bukwang Pharmaceutical vs JW Pharmaceutical
JW Pharmaceutical ranks higher overall — 360 rank 95 vs 53.
JW Pharmaceutical leads on Value (69 vs 39) and Quality (74 vs 47). Bukwang Pharmaceutical leads on Growth (64 vs 56). The two are close on Safety and Sentiment.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | South Korea | South Korea |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | Small | Small |
| ISIN | KR7003000007 | KR7001060003 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 53 | 95 |
| Value | 39 | 69 |
| Quality | 47 | 74 |
| Growth | 64 | 56 |
| Safety | 61 | 61 |
| Sentiment | 43 | 45 |
| Quality details | ||
| Profitability | 61 | 92 |
| Cash Truth | 33 | 55 |
Bukwang Pharmaceutical vs Kwangdong PharmaceuticalBukwang Pharmaceutical vs Dong-A STBukwang Pharmaceutical vs Bora PharmaceuticalsBukwang Pharmaceutical vs Reyon PharmaceuticalAdd a third stock →
Full analyses: Bukwang Pharmaceutical · JW Pharmaceutical
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100